Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Primary Hyperparathyroidism With Denosumab and Cinacalcet.

NCT03027557 is registered in ClinicalTrials.gov with Peter Vestergaard as lead sponsor.

NCT NCT03027557
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03027557 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Primary Hyperparathyroidism With Denosumab and Cinacalcet.
Lead sponsor
Peter Vestergaard
Phase
Phase 3
Overall status
Completed
Start date
March 1, 2017
Completion date
September 12, 2019
Enrollment
46 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parathyroid adenoma, parathyroid hyperplasia, primary hyperparathyroidism